GENWORTH FINANCIAL INC, 8-K filed on 6/11/2012
Current report filing
Document and Entity Information
12 Months Ended
Dec. 31, 2011
Document Information [Line Items]
 
Document Type
8-K 
Amendment Flag
false 
Document Period End Date
Dec. 31, 2011 
Trading Symbol
GNW 
Entity Registrant Name
GENWORTH FINANCIAL INC 
Entity Central Index Key
0001276520 
Consolidated Balance Sheets (USD $)
In Millions, unless otherwise specified
Dec. 31, 2011
Dec. 31, 2010
Assets
 
 
Fixed maturity securities available-for-sale, at fair value
$ 58,295 
$ 55,183 
Equity securities available-for-sale, at fair value
361 
332 
Commercial mortgage loans
6,092 
6,718 
Restricted commercial mortgage loans related to securitization entities
411 
507 
Policy loans
1,549 
1,471 
Other invested assets
4,819 
3,854 
Restricted other invested assets related to securitization entities ($376 and $370 at fair value)
377 
372 
Total investments
71,904 
68,437 
Cash and cash equivalents
4,488 
3,132 
Accrued investment income
691 
733 
Deferred acquisition costs
5,193 
5,195 1
Intangible assets
580 
744 
Goodwill
1,253 
1,329 
Reinsurance recoverable
16,998 
17,206 
Other assets
958 
810 
Deferred tax asset
 
1,111 
Separate account assets
10,122 
11,666 
Total assets
112,187 
110,363 
Liabilities and stockholders' equity
 
 
Future policy benefits
32,175 
30,905 
Policyholder account balances
26,345 
26,978 
Liability for policy and contract claims
7,620 2
6,933 2 3
Unearned premiums
4,223 
4,507 
Other liabilities ($210 and $150 other liabilities related to securitization entities)
6,308 
6,085 
Borrowings related to securitization entities ($48 and $51 at fair value)
396 
494 
Non-recourse funding obligations
3,256 
3,437 
Long-term borrowings
4,726 
4,952 
Deferred tax liability
838 
861 
Separate account liabilities
10,122 
11,666 
Total liabilities
96,009 
96,818 
Commitments and contingencies
   
   
Stockholders' equity:
 
 
Class A common stock, $0.001 par value; 1.5 billion shares authorized; 579 million and 578 million shares issued as of December 31, 2011 and 2010, respectively; 491 million and 490 million shares outstanding as of December 31, 2011 and 2010, respectively
Additional paid-in capital
12,136 
12,107 
Net unrealized investment gains (losses):
 
 
Net unrealized gains (losses) on securities not other-than-temporarily impaired
1,617 
41 
Net unrealized gains (losses) on other-than-temporarily impaired securities
(132)
(121)
Net unrealized investment gains (losses)
1,485 
(80)
Derivatives qualifying as hedges
2,009 
924 
Foreign currency translation and other adjustments
553 
662 
Total accumulated other comprehensive income (loss)
4,047 
1,506 
Retained earnings
1,584 
1,535 
Treasury stock, at cost (88 million shares as of December 31, 2011 and 2010)
(2,700)
(2,700)
Total Genworth Financial, Inc.'s stockholders' equity
15,068 
12,449 
Noncontrolling interests
1,110 
1,096 
Total stockholders' equity
16,178 
13,545 
Total liabilities and stockholders' equity
$ 112,187 
$ 110,363 
Consolidated Balance Sheets (Parenthetical) (USD $)
In Millions, except Share data, unless otherwise specified
Dec. 31, 2011
Dec. 31, 2010
Restricted other invested assets related to securitization entities, at fair value
$ 376 
$ 370 
Other liabilities related to securitization entities
210 
150 
Borrowings related to securitization entities, at fair value
$ 48 
$ 51 
Class A Common Stock, par value
$ 0.001 
$ 0.001 
Class A Common Stock, shares authorized
1,500,000,000 
1,500,000,000 
Class A Common Stock, shares issued
579,000,000 
578,000,000 
Class A Common Stock, shares outstanding
491,000,000 
490,000,000 
Treasury stock, shares
88,000,000 
88,000,000 
Consolidated Statements Of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Revenues:
 
 
 
Premiums
$ 5,705 
$ 5,854 
$ 6,019 
Net investment income
3,380 
3,266 
3,033 
Net investment gains (losses)
(220)
(143)
(1,041)
Insurance and investment product fees and other
1,503 
1,112 
1,058 
Total revenues
10,368 
10,089 
9,069 
Benefits and expenses:
 
 
 
Benefits and other changes in policy reserves
5,941 
6,001 
5,866 
Interest credited
794 
841 
984 
Acquisition and operating expenses, net of deferrals
2,294 
2,217 
2,115 
Amortization of deferred acquisition costs and intangibles
598 
626 
569 
Goodwill impairment
29 
 
 
Interest expense
506 
457 
393 
Total benefits and expenses
10,162 
10,142 
9,927 
Income (loss) before income taxes
206 
(53)
(858)
Provision (benefit) for income taxes
18 
(248)
(415)
Net income (loss)
188 
195 
(443)
Less: net income attributable to noncontrolling interests
139 
143 
61 
Net income (loss) available to Genworth Financial, Inc.'s common stockholders
49 
52 
(504)
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per common share:
 
 
 
Basic
$ 0.10 1
$ 0.11 1
$ (1.12)1
Diluted
$ 0.10 1
$ 0.11 1
$ (1.12)1
Weighted-average common shares outstanding:
 
 
 
Basic
490.6 
489.3 
451.1 
Diluted
493.5 2
493.9 2
451.1 2
Supplemental disclosures:
 
 
 
Total other-than-temporary impairments
(118)
(122)
(1,499)
Portion of other-than-temporary impairments included in other comprehensive income (loss)
(14)
(86)
441 
Net other-than-temporary impairments
(132)
(208)
(1,058)
Other investments gains (losses)
(88)
65 
17 
Total net investment gains (losses)
$ (220)
$ (143)
$ (1,041)
Consolidated Statements Of Comprehensive Income (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Net income (loss)
$ 188 
$ 195 
$ (443)
Other comprehensive income (loss), net of taxes:
 
 
 
Net unrealized gains (losses) on securities not other-than-temporarily impaired
1,615 
950 
3,056 
Net unrealized gains (losses) on other-than-temporarily impaired securities
(11)
126 
14 
Derivatives qualifying as hedges
1,085 
122 
(359)
Foreign currency translation and other adjustments
(135)
286 
734 
Total other comprehensive income (loss)
2,554 
1,484 
3,445 
Total comprehensive income (loss)
2,742 
1,679 
3,002 
Less: comprehensive income attributable to noncontrolling interests
152 
209 
156 
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders
$ 2,590 
$ 1,470 
$ 2,846 
Consolidated Statements Of Changes In Stockholders' Equity (USD $)
In Millions, unless otherwise specified
Total
Common stock
Additional Paid-in Capital
Accumulated other comprehensive income (loss)
Retained earnings
Treasury stock, at cost
Total Genworth Financial, Inc.'s stockholders' equity
Noncontrolling interests
Balance at Dec. 31, 2008
$ 7,583 
$ 1 
$ 11,477 
$ (3,101)
$ 1,906 
$ (2,700)
$ 7,583 
 
Cumulative effect of change in accounting, net of taxes and other adjustments
 
 
(349)
355 
 
 
Initial sale of subsidiary shares to noncontrolling interests
683 
 
(73)
(60)
 
 
(133)
816 
Additional sale of subsidiary shares to noncontrolling interests
84 
 
(3)
(12)
 
 
(15)
99 
Issuance of common stock
622 
 
622 
 
 
 
622 
 
Comprehensive income (loss):
 
 
 
 
 
 
 
 
Net income (loss)
(443)
 
 
 
(504)
 
(504)
61 
Net unrealized gains (losses) on securities not other- than-temporarily impaired
3,056 
 
 
3,039 
 
 
3,039 
17 
Net unrealized gains (losses) on other-than-temporarily impaired securities
14 
 
 
14 
 
 
14 
 
Derivatives qualifying as hedges
(359)
 
 
(359)
 
 
(359)
 
Foreign currency translation and other adjustments
734 
 
 
656 
 
 
656 
78 
Total comprehensive income (loss)
3,002 
 
 
 
 
 
2,846 
156 
Dividends to noncontrolling interests
(10)
 
 
 
 
 
 
(10)
Stock-based compensation expense and exercises and other
23 
 
23 
 
 
 
23 
 
Balance at Dec. 31, 2009
11,993 
12,046 
(172)
1,757 
(2,700)
10,932 
1,061 
Comprehensive income (loss):
 
 
 
 
 
 
 
 
Net income (loss)
195 
 
 
 
 
 
 
 
Other capital transactions
 
 
23 
 
 
 
 
 
Balance at Mar. 31, 2010
 
 
 
 
 
 
 
 
Balance at Dec. 31, 2009
11,993 
12,046 
(172)
1,757 
(2,700)
10,932 
1,061 
Cumulative effect of change in accounting, net of taxes and other adjustments
(15)
 
 
260 
(275)
 
(15)
 
Repurchase of subsidiary shares
(131)
 
 
 
 
 
 
(131)
Comprehensive income (loss):
 
 
 
 
 
 
 
 
Net income (loss)
195 
 
 
 
52 
 
52 
143 
Net unrealized gains (losses) on securities not other- than-temporarily impaired
950 
 
 
939 
 
 
939 
11 
Net unrealized gains (losses) on other-than-temporarily impaired securities
126 
 
 
126 
 
 
126 
 
Derivatives qualifying as hedges
122 
 
 
122 
 
 
122 
 
Foreign currency translation and other adjustments
286 
 
 
231 
 
 
231 
55 
Total comprehensive income (loss)
1,679 
 
 
 
 
 
1,470 
209 
Dividends to noncontrolling interests
(43)
 
 
 
 
 
 
(43)
Stock-based compensation expense and exercises and other
38 
 
38 
 
 
 
38 
 
Other capital transactions
24 
 
23 
 
 
24 
 
Balance at Dec. 31, 2010
13,545 
12,107 
1,506 
1,535 
(2,700)
12,449 
1,096 
Repurchase of subsidiary shares
(71)
 
 
 
 
 
 
(71)
Comprehensive income (loss):
 
 
 
 
 
 
 
 
Net income (loss)
188 
 
 
 
49 
 
49 
139 
Net unrealized gains (losses) on securities not other- than-temporarily impaired
1,615 
 
 
1,576 
 
 
1,576 
39 
Net unrealized gains (losses) on other-than-temporarily impaired securities
(11)
 
 
(11)
 
 
(11)
 
Derivatives qualifying as hedges
1,085 
 
 
1,085 
 
 
1,085 
 
Foreign currency translation and other adjustments
(135)
 
 
(109)
 
 
(109)
(26)
Total comprehensive income (loss)
2,742 
 
 
 
 
 
2,590 
152 
Dividends to noncontrolling interests
(67)
 
 
 
 
 
 
(67)
Stock-based compensation expense and exercises and other
29 
 
29 
 
 
 
29 
 
Balance at Dec. 31, 2011
$ 16,178 
$ 1 
$ 12,136 
$ 4,047 
$ 1,584 
$ (2,700)
$ 15,068 
$ 1,110 
Consolidated Statements Of Cash Flows (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities:
 
 
 
Net income (loss)
$ 188 
$ 195 
$ (443)
Adjustments to reconcile net income (loss) to net cash from operating activities:
 
 
 
Amortization of fixed maturity discounts and premiums and limited partnerships
(77)
(55)
84 
Net investment losses (gains)
220 
143 
1,041 
Charges assessed to policyholders
(690)
(506)
(442)
Acquisition costs deferred
(637)
(587)
(476)
Amortization of deferred acquisition costs and intangibles
598 
626 
569 
Goodwill impairment
29 
 
 
Deferred income taxes
(352)
(333)
(498)
Gain on sale of subsidiary
(36)
 
(4)
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments
1,451 
(100)
(59)
Stock-based compensation expense
31 
44 
26 
Change in certain assets and liabilities:
 
 
 
Accrued investment income and other assets
(140)
(33)
(90)
Insurance reserves
2,507 
2,413 
2,811 
Current tax liabilities
131 
(173)
(119)
Other liabilities and other policy-related balances
(98)
(298)
(469)
Net cash from operating activities
3,125 
1,336 
1,931 
Cash flows from investing activities:
 
 
 
Fixed maturity securities
5,233 
4,589 
4,105 
Commercial mortgage loans
912 
769 
710 
Restricted commercial mortgage loans related to securitization entities
96 
52 
 
Proceeds from sales of investments:
 
 
 
Fixed maturity and equity securities
6,284 
4,643 
5,808 
Purchases and originations of investments:
 
 
 
Fixed maturity and equity securities
(11,885)
(13,237)
(9,869)
Commercial mortgage loans
(300)
(105)
 
Other invested assets, net
(527)
1,579 
(314)
Policy loans, net
(79)
(68)
431 
Net cash transferred related to the sale of a subsidiary
211 
 
(51)
Payments for businesses purchased, net of cash acquired
(4)
(37)
 
Net cash from investing activities
(59)
(1,815)
820 
Cash flows from financing activities:
 
 
 
Deposits to universal life and investment contracts
2,664 
2,737 
2,271 
Withdrawals from universal life and investment contracts
(3,688)
(4,429)
(7,975)
Short-term borrowings and other, net
(38)
(777)
(375)
Redemption and repurchase of non-recourse funding obligations
(130)
(6)
(12)
Proceeds from the issuance of long-term debt
545 
1,204 
298 
Repayment and repurchase of long-term debt
(760)
(6)
(898)
Proceeds from issuance of common stock
 
 
622 
Repayment of borrowings related to securitization entities
(96)
(61)
 
Repurchase of subsidiary shares
(71)
(131)
 
Dividends paid to noncontrolling interests
(67)
(43)
(10)
Proceeds from the sale of subsidiary shares to noncontrolling interests
 
 
770 
Net cash from financing activities
(1,641)
(1,512)
(5,309)
Effect of exchange rate changes on cash and cash equivalents
(69)
121 
232 
Net change in cash and cash equivalents
1,356 
(1,870)
(2,326)
Cash and cash equivalents at beginning of period
3,132 
5,002 
7,328 
Cash and cash equivalents at end of period
$ 4,488 
$ 3,132 
$ 5,002 
Nature of Business and Formation of Genworth
Nature of Business and Formation of Genworth

(1) Nature of Business and Formation of Genworth

Genworth Financial, Inc. (“Genworth”) was incorporated in Delaware on October 23, 2003 as an indirect subsidiary of General Electric Company (“GE”) in preparation for the initial public offering (“IPO”) of Genworth’s common stock, which was completed on May 28, 2004. In connection with our IPO, Genworth acquired substantially all of the assets and liabilities of GE Financial Assurance Holdings, Inc. (“GEFAHI”). The transaction was accounted for at book value as a transfer between entities under common control and is referred to as our corporate formation.

The accompanying financial statements include on a consolidated basis the accounts of Genworth and our affiliate companies in which we hold a majority voting interest or power to direct activities of certain variable interest entities (“VIEs”), which we refer to as the “Company,” “we,” “us” or “our” unless the context otherwise requires.

We have the following operating segments:

 

   

U.S. Life Insurance. We offer and manage a variety of insurance and fixed annuity products. Our primary insurance products include life and long-term care insurance.

 

   

International Protection. We are a leading provider of payment protection coverages (referred to as lifestyle protection) in multiple European countries. Our lifestyle protection insurance products primarily help consumers meet specified payment obligations should they become unable to pay due to accident, illness, involuntary unemployment, disability or death.

 

   

Wealth Management. We offer and manage a variety of wealth management products that include managed account programs together with advisor support and financial planning services.

 

   

International Mortgage Insurance. We are a leading provider of mortgage insurance products and related services in Canada, Australia, Mexico and multiple European countries. Our products predominantly insure prime-based, individually underwritten residential mortgage loans, also known as flow mortgage insurance. On a limited basis, we also provide mortgage insurance on a structured, or bulk, basis that aids in the sale of mortgages to the capital markets and helps lenders manage capital and risk. Additionally, we offer services, analytical tools and technology that enable lenders to operate efficiently and manage risk.

 

   

U.S. Mortgage Insurance. In the United States, we offer mortgage insurance products predominantly insuring prime-based, individually underwritten residential mortgage loans, also known as flow mortgage insurance. We selectively provide mortgage insurance on a bulk basis with essentially all of our bulk writings prime-based. Additionally, we offer services, analytical tools and technology that enable lenders to operate efficiently and manage risk.

 

   

Runoff. The Runoff segment includes the results of non-strategic products which are no longer actively sold. Our non-strategic products include our variable annuity, variable life insurance, institutional, corporate-owned life insurance and Medicare supplement insurance products. Institutional products consist of: funding agreements, funding agreements backing notes (“FABNs”) and guaranteed investment contracts (“GICs”). In January 2011, we discontinued new sales of retail and group variable annuities while continuing to service our existing blocks of business. Effective October 1, 2011, we completed the sale of our Medicare supplement insurance business.

We also have Corporate and Other activities which include debt financing expenses that are incurred at our holding company level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other non-core businesses that are managed outside of our operating segments.

Summary of Significant Accounting Policies
Summary of Significant Accounting Policies

(2) Summary of Significant Accounting Policies

Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. All significant intercompany accounts and transactions have been eliminated in consolidation. Certain prior year amounts have been reclassified to conform to the current year presentation.

 

a) Premiums

For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims.

For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums.

Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances.

b) Net Investment Income and Net Investment Gains and Losses

Investment income is recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification.

Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method, used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return.

c) Insurance and Investment Product Fees and Other

Insurance and investment product fees and other consist primarily of insurance charges assessed on universal and term universal life insurance contracts, fees assessed against customer account values and commission income. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered.

d) Investment Securities

At the time of purchase, we designate our investment securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities is comprised primarily of investment grade securities. Changes in the fair value of available-for-sale investments, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Trading securities are included in other invested assets in our consolidated balance sheets and primarily represent fixed maturity securities where we utilized the fair value option.

 

Other-Than-Temporary Impairments On Available-For-Sale Securities

As of each balance sheet date, we evaluate securities in an unrealized loss position for other-than-temporary impairments. For debt securities, we consider all available information relevant to the collectability of the security, including information about past events, current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilize performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data is benchmarked against third-party sources.

Prior to adoption of new accounting guidance related to the recognition and presentation of other-than-temporary impairments on April 1, 2009, we recognized an other-than-temporary impairment on debt securities in an unrealized loss position when we did not expect full recovery of value or did not have the intent and ability to hold such securities until they had fully recovered their amortized cost. The recognition of other-than-temporary impairments prior to April 1, 2009 represented the entire difference between the amortized cost and fair value with this difference being recorded in net income (loss) as an adjustment to the amortized cost of the security.

Beginning on April 1, 2009, we recognize other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists:

 

   

we do not expect full recovery of our amortized cost based on the estimate of cash flows expected to be collected,

 

   

we intend to sell a security or

 

   

it is more likely than not that we will be required to sell a security prior to recovery.

For other-than-temporary impairments recognized during the period, we present the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income.

Total other-than-temporary impairments are calculated as the difference between the amortized cost and fair value that emerged in the current period. For other-than-temporarily impaired securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, total other-than-temporary impairments are adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represent the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities.

For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represents the difference between the current fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security is recorded as a separate component in OCI until the security is sold or until we record an other-than-temporary impairment where we intend to sell the security or will be required to sell the security prior to recovery.

To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, we determine our best estimate of the present value of the cash flows expected to be collected from a security by discounting these cash flows at the current effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows is lower than the amortized cost of the security, the difference between the present value and amortized cost represents the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI.

The evaluation of other-than-temporary impairments is subject to risks and uncertainties and is intended to determine the appropriate amount and timing for recognizing an impairment charge. The assessment of whether such impairment has occurred is based on management’s best estimate of the cash flows expected to be collected at the individual security level. We regularly monitor our investment portfolio to ensure that securities that may be other-than-temporarily impaired are identified in a timely manner and that any impairment charge is recognized in the proper period.

 

While the other-than-temporary impairment model for debt securities generally includes fixed maturity securities, there are certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depends on whether there has been any evidence of deterioration in credit of the issuer. Under certain circumstances, evidence of deterioration in credit of the issuer may result in the application of the equity securities impairment model.

For equity securities, we recognize an impairment charge in the period in which we determine that the security will not recover to book value within a reasonable period. We determine what constitutes a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period does not exceed 18 months for common equity securities. We measure other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value.

e) Fair Value Measurements

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value.

Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

 

   

Level 1—Quoted prices for identical instruments in active markets.

 

   

Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.

 

   

Level 3—Instruments whose significant value drivers are unobservable.

Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded derivatives and actively traded mutual fund investments.

Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable, information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps.

Level 3 is comprised of financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In limited instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data.

As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 17 for additional information related to fair value measurements.

f) Commercial Mortgage Loans

Commercial mortgage loans are stated at principal amounts outstanding, net of deferred expenses and allowance for loan loss. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date.

“Impaired” loans are defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Impaired loans are carried on a non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is unlikely, or when the collection of principal or interest is 90 days or more past due. Income on impaired loans is not recognized until the loan is sold or the cash received exceeds the carrying amount recorded.

We evaluate the impairment of commercial mortgage loans first on an individual loan basis. If an individual loan is not deemed impaired, then we evaluate the remaining loans collectively to determine whether an impairment should be recorded.

For individually impaired loans, we record an impairment charge when it is probable that a loss has been incurred. The impairment is recorded as an increase in the allowance for loan losses. All losses of principal are charged to the allowance for loan losses in the period in which the loan is deemed to be uncollectible.

For loans that are not individually impaired where we evaluate the loans collectively, the allowance for loan losses is maintained at a level that we determine is adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilizes an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next twelve months. Key inputs into our evaluation include debt service coverage ratios, loan-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model. The actual amounts realized could differ in the near term from the amounts assumed in arriving at the allowance for loan losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses).

For commercial mortgage loans classified as held-for-sale, each loan is carried at the lower of cost or market and is included in commercial mortgage loans in our consolidated balance sheets. See note 4 for additional disclosures related to commercial mortgage loans.

g) Securities Lending Activity

In the United States and Canada, we engage in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintain effective control over all loaned securities and, therefore, continue to report such securities as fixed maturity securities on the consolidated balance sheets. We are currently indemnified against counterparty credit risk by the intermediary.

Under the securities lending program in the United States, the borrower is required to provide collateral, which can consist of cash or government securities, on a daily basis in amounts equal to or exceeding 102% of the applicable securities loaned. Currently, we only accept cash collateral from borrowers under the program. Cash collateral received by us on securities lending transactions is reflected in other invested assets with an offsetting liability recognized in other liabilities for the obligation to return the collateral. Any cash collateral received is reinvested by our custodian based upon the investment guidelines provided within our agreement. In the United States, the reinvested cash collateral is primarily invested in a money market fund approved by the National Association of Insurance Commissioners (“NAIC”), U.S. and foreign government securities, U.S. government agency securities, asset-backed securities and corporate debt securities. As of December 31, 2011 and 2010, the fair value of securities loaned under our securities lending program in the United States was $0.4 billion and $0.5 billion, respectively. As of December 31, 2011 and 2010, the fair value of collateral held under our securities lending program in the United States was $0.4 billion and $0.5 billion, respectively, and the offsetting obligation to return collateral of $0.4 billion and $0.5 billion, respectively, was included in other liabilities in the consolidated balance sheets. We did not have any non-cash collateral provided by the borrower in our securities lending program in the United States as of December 31, 2011 and 2010.

Under our securities lending program in Canada, the borrower is required to provide collateral consisting of government securities on a daily basis in amounts equal to or exceeding 105% of the fair value of the applicable securities loaned. Securities received from counterparties as collateral are not recorded on our consolidated balance sheet given that the risk and rewards of ownership is not transferred from the counterparties to us in the course of such transactions. Additionally, there was no cash collateral as cash collateral is not permitted as an acceptable form of collateral under the program. In Canada, the lending institution must be included on the approved Securities Lending Borrowers List with the Canadian regulator and the intermediary must be rated at least “AA-” by Standard & Poor’s Financial Services LLC. As of December 31, 2011 and 2010, the fair value of securities loaned under our securities lending program in Canada was $0.3 billion. Prior to the second quarter of 2011, we recorded non-cash collateral in other invested assets with a corresponding liability in other liabilities representing our obligation to return the non-cash collateral. Since we do not have rights to sell or pledge the non-cash collateral, we determined the gross presentation of these amounts was not required and changed our presentation of these amounts beginning in the second quarter of 2011.

h) Repurchase Agreements

We have a repurchase program in which we sell an investment security at a specified price and agree to repurchase that security at another specified price at a later date. Repurchase agreements are treated as collateralized financing transactions and are carried at the amounts at which the securities will be subsequently reacquired, including accrued interest, as specified in the respective agreement. The market value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities. As of December 31, 2011 and 2010, the fair value of securities pledged under the repurchase program was $1.7 billion and the repurchase obligation of $1.5 billion and $1.7 billion, respectively, was included in other liabilities in the consolidated balance sheets.

i) Cash and Cash Equivalents

Certificates of deposit, money market funds and other time deposits with original maturities of 90 days or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than 90 days but less than one year at the time of acquisition are considered short-term investments.

j) Deferred Acquisition Costs

Acquisition costs include costs that are related directly to the successful acquisition of new and renewal insurance policies and investment contracts. Such costs are deferred and amortized as follows:

Long-Duration Contracts. Acquisition costs include commissions in excess of ultimate renewal commissions and for contracts and policies issued, some other costs such as underwriting, medical inspection and issuance expenses. Amortization for traditional long-duration insurance products is determined as a level proportion of premium based on commonly accepted actuarial methods and reasonable assumptions about mortality, morbidity, lapse rates, expenses and future yield on related investments established when the contract or policy is issued. Amortization is adjusted each period to reflect policy lapse or termination rates as compared to anticipated experience. Amortization for annuity contracts without significant mortality risk and for investment and universal life insurance products is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for the unlocking of underlying key assumptions relating to future gross profits based on experience studies.

Short-Duration Contracts. Acquisition costs consist primarily of commissions and premium taxes and are amortized ratably over the terms of the underlying policies.

 

We regularly review all of these assumptions and periodically test DAC for recoverability. For deposit products, if the current present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to income is recorded for additional DAC amortization, and for certain products, an increase in benefit reserves may be required. For other products, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to income is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability.

k) Intangible Assets

Present Value of Future Profits. In conjunction with the acquisition of a block of insurance policies or investment contracts, a portion of the purchase price is assigned to the right to receive future gross profits arising from existing insurance and investment contracts. This intangible asset, called PVFP, represents the actuarially estimated present value of future cash flows from the acquired policies. PVFP is amortized, net of accreted interest, in a manner similar to the amortization of DAC.

We regularly review all of these assumptions and periodically test PVFP for recoverability. For deposit products, if the current present value of estimated future gross profits is less than the unamortized PVFP for a line of business, a charge to income is recorded for additional PVFP amortization. For other products, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized PVFP), a charge to income is recorded for additional PVFP amortization or for increased benefit reserves. For the years ended December 31, 2011, 2010 and 2009, no charges to income were recorded as a result of our PVFP recoverability or loss recognition testing.

Deferred Sales Inducements to Contractholders. We defer sales inducements to contractholders for features on variable annuities that entitle the contractholder to an incremental amount to be credited to the account value upon making a deposit, and for fixed annuities with crediting rates higher than the contract’s expected ongoing crediting rates for periods after the inducement. Deferred sales inducements to contractholders are reported as a separate intangible asset and amortized in benefits and other changes in policy reserves using the same methodology and assumptions used to amortize DAC.

Other Intangible Assets. We amortize the costs of other intangibles over their estimated useful lives unless such lives are deemed indefinite. Amortizable intangible assets are tested for impairment based on undiscounted cash flows, which requires the use of estimates and judgment, and, if impaired, written down to fair value based on either discounted cash flows or appraised values. Intangible assets with indefinite lives are tested at least annually for impairment and written down to fair value as required.

l) Goodwill

Goodwill is not amortized but is tested for impairment at least annually and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. We test goodwill using a fair value approach, which requires the use of estimates and judgment, at the “reporting unit” level. A reporting unit is the operating segment, or a business one level below that operating segment (the “component” level) if discrete financial information is prepared and regularly reviewed by management at the component level. We recognize an impairment charge for any amount by which the carrying amount of a reporting unit’s goodwill exceeds its fair value.

The determination of fair value for our reporting units is primarily based on an income approach whereby we use discounted cash flows for each reporting unit. When available and as appropriate, we use market approaches or other valuation techniques to corroborate discounted cash flow results. The discounted cash flow model used for each reporting unit is based on either: operating income or statutory distributable income, depending on the reporting unit being valued.

The cash flows used to determine fair value are dependent on a number of significant management assumptions based on our historical experience, our expectations of future performance, and expected economic environment. Our estimates are subject to change given the inherent uncertainty in predicting future performance and cash flows, which are impacted by such things as policyholder behavior, competitor pricing, new product introductions and specific industry and market conditions. Additionally, the discount rate used in our discounted cash flow approach is based on management’s judgment of the appropriate rate for each reporting unit based on the relative risk associated with the projected cash flows.

See note 8 for additional information related to goodwill and impairments recorded.

 

m) Reinsurance

Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting.

n) Derivatives

Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions.

On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (fair value, cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in income.

We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure hedge ineffectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument.

We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur.

For all qualifying and highly effective cash flow hedges, the effective portion of changes in fair value of the derivative instrument is reported as a component of OCI. The ineffective portion of changes in fair value of the derivative instrument is reported as a component of income. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in income. When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects income; however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into income when income is impacted by the variability of the cash flow of the hedged item.

For all qualifying and highly effective fair value hedges, the changes in fair value of the derivative instrument are reported in income. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in income. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair value hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, but the hedged asset or liability will no longer be adjusted for changes in fair value. In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value in the consolidated balance sheets, with changes in its fair value recognized in the current period as income.

We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument.

 

If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in the current period in income. If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in the current period in income.

Changes in the fair value of non-qualifying derivatives, including embedded derivatives, changes in fair value of certain derivatives and related hedged items in fair value hedge relationships and hedge ineffectiveness on cash flow hedges are reported in net investment gains (losses).

o) Separate Accounts

The separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the variable annuity contractholders and variable life insurance policyholders. We assess mortality and expense risk fees and administration charges on the assets allocated to the separate accounts. The separate account assets are carried at fair value and are equal to the liabilities that represent the contractholders’ and policyholders’ equity in those assets.

p) Insurance Reserves

Future Policy Benefits

We include insurance-type contracts, such as traditional life insurance, in the liability for future policy benefits. Insurance-type contracts are broadly defined to include contracts with significant mortality and/or morbidity risk. The liability for future benefits of insurance contracts is the present value of such benefits less the present value of future net premiums based on mortality, morbidity and other assumptions, which are appropriate at the time the policies are issued or acquired. These assumptions are periodically evaluated for potential reserve deficiencies. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. Reserves for cancelable accident and health insurance are based upon unearned premiums, claims incurred but not reported and claims in the process of settlement. This estimate is based on our historical experience and that of the insurance industry, adjusted for current trends. Any changes in the estimated liability are reflected in income as the estimates are revised.

Policyholder Account Balances

We include investment-type contracts and our universal life insurance contracts in the liability for policyholder account balances. Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management.

q) Liability for Policy and Contract Claims

The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.

For our mortgage insurance policies, reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we begin to provide for the ultimate claim payment relating to a potential claim on a defaulted loan when the status of that loan first goes delinquent. Over time, as the status of the underlying delinquent loans move toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase.

 

Management considers the liability for policy and contract claims provided to be satisfactory to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the reserves are reviewed continuously and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses and loss expenses greater or less than the liability for policy and contract claims provided.

r) Unearned Premiums

For single premium insurance contracts, we recognize premiums over the policy life in accordance with the expected pattern of risk emergence. We recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected in current period income. For the years ended December 31, 2011, 2010 and 2009, we updated our premium recognition factors for our international mortgage insurance business. These updates included the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. In 2011, 2010 and 2009, adjustments associated with this update resulted in an increase in earned premiums of $46 million, $52 million and $49 million, respectively.

s) Stock-Based Compensation

We determine a grant date fair value and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards.

t) Employee Benefit Plans

We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans.

Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI.

u) Income Taxes

We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts.

Effective with the period starting January 1, 2011, our companies intend to elect to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). Such election can only be made with the filing of the first life/non-life consolidated return which is anticipated to be filed on or before September 15, 2012. All companies domesticated in the United States and our Bermuda subsidiaries which have elected to be taxed as U.S. domestic companies will be included in the life/non-life consolidated return as allowed by the tax law and regulations. A new tax sharing agreement which is anticipated to be substantially similar to the prior separate agreements, but applicable to all the includable companies, will be provided to the appropriate state insurance regulators for approval. Intercompany balances relating to the impacts of the new agreement will be settled with the insurance companies after approval is received from the insurance regulators. Intercompany balances under all agreements are settled at least annually. For years before 2011, our U.S. non-life insurance entities were included in the consolidated federal income tax return of Genworth and subject to a tax sharing arrangement that allocated tax on a separate company basis but provided benefit for current utilization of losses and credits. Also, our U.S. life insurance entities filed a consolidated life insurance federal income tax return, and were subject to a separate tax sharing agreement, as approved by state insurance regulators, which allocated taxes on a separate company basis but provided benefit for current utilization of losses and credits.

Our subsidiaries based in Bermuda are treated as U.S. life insurance companies under provisions of the U.S. Internal Revenue Code. Jurisdictions outside the United States in which our various subsidiaries incur significant taxes include Australia, Canada and the United Kingdom.

v) Foreign Currency Translation

The determination of the functional currency is made based on the appropriate economic and management indicators. The assets and liabilities of foreign operations are translated into U.S. dollars at the exchange rates in effect at the consolidated balance sheet date. Translation adjustments are included as a separate component of accumulated other comprehensive income (loss). Revenues and expenses of the foreign operations are translated into U.S. dollars at the average rates of exchange during the period of the transaction. Gains and losses from foreign currency transactions are reported in income and have not been material in any years presented in our consolidated statements of income.

w) Variable Interest Entities

We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and, accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by beneficial interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs.

Our primary involvement related to VIEs includes securitization transactions, certain investments and certain mortgage insurance policies.

We have retained interests in VIEs where we are the servicer and transferor of certain assets that were sold to a newly created VIE. Additionally, for certain securitization transactions, we were the transferor of certain assets that were sold to a newly created VIE but did not retain any beneficial interest in the VIE other than acting as the servicer of the underlying assets.

We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or alternative investments. Our involvement in these structures typically represent a passive investment in the returns generated by the VIE and typically do not result in having significant influence over the economic performance of the VIE.

We also provide mortgage insurance on certain residential mortgage loans originated and securitized by third parties using VIEs to issue mortgage-backed securities. While we provide mortgage insurance on the underlying loans, we do not typically have any on-going involvement with the VIE other than our mortgage insurance coverage and do not act in a servicing capacity for the underlying loans held by the VIE.

On January 1, 2010, we were required to consolidate certain VIEs. See note 18 for additional information related to these consolidated entities. As of December 31, 2009, we were not required to consolidate any VIEs where there were third-party beneficial interest holders.

x) Accounting Changes

Testing Goodwill For Impairment

In September 2011, the Financial Accounting Standards Board (the “FASB”) issued new accounting guidance related to goodwill impairment testing. The new guidance permits the use of a qualitative assessment prior to, and potentially instead of, the two step quantitative goodwill impairment test. We elected to early adopt this new guidance effective on July 1, 2011 in order to apply the new guidance in our annual goodwill impairment testing performed during the third quarter. The adoption of this new accounting guidance did not have an impact on our consolidated financial statements.

 

A Creditor’s Determination of Whether a Restructuring Is a Troubled Debt Restructuring

On July 1, 2011, we adopted new accounting guidance related to additional disclosures for troubled debt restructurings. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

When to Perform Step 2 of the Goodwill Impairment Test For Reporting Units With Zero or Negative Carrying Value

On January 1, 2011, we adopted new accounting guidance related to goodwill impairment testing when a reporting unit’s carrying value is zero or negative. This guidance did not impact our consolidated financial statements upon adoption, as all of our reporting units with goodwill balances have positive carrying values.

How Investments Held Through Separate Accounts Affect an Insurer’s Consolidation Analysis of Those Investments

On January 1, 2011, we adopted new accounting guidance related to how investments held through separate accounts affect an insurer’s consolidation analysis of those investments. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Fair Value Measurements and Disclosures—Improving Disclosures about Fair Value Measurements

On January 1, 2011, we adopted new accounting guidance related to additional disclosures about purchases, sales, issuances and settlements in the rollforward of Level 3 fair value measurements. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Disclosures Related To Financing Receivables

On December 31, 2010, we adopted new accounting guidance related to additional disclosures about the credit quality of loans, lease receivables and other long-term receivables and the related allowance for credit losses. Certain other additional disclosures were effective for us on March 31, 2011. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Scope Exception for Embedded Credit Derivatives

On July 1, 2010, we adopted new accounting guidance related to embedded credit derivatives. This accounting guidance clarified the scope exception for embedded credit derivatives and when those features would be bifurcated from the host contract. Under the new accounting guidance, only embedded credit derivative features that are in the form of subordination of one financial instrument to another would not be subject to the bifurcation requirements. Accordingly, upon adoption, we were required to bifurcate embedded credit derivatives that no longer qualified under the amended scope exception. In conjunction with our adoption, we elected fair value option for certain fixed maturity securities. The following summarizes the components for the cumulative effect adjustment recorded on July 1, 2010 related to the adoption of this new accounting guidance:

 

(Amounts in millions)

   Accumulated other
comprehensive
income (loss)
    Retained
earnings
    Total
stockholders’
equity
 

Investment securities

   $ 267      $ (267   $ —     

Adjustment to DAC

     (4     1        (3

Adjustment to sales inducements

     (1     1        —     

Provision for income taxes

     (93     94        1   
  

 

 

   

 

 

   

 

 

 

Net cumulative effect adjustment

   $ 169      $ (171   $ (2
  

 

 

   

 

 

   

 

 

 

For certain securities where the embedded credit derivative would require bifurcation, we elected the fair value option to carry the entire instrument at fair value to reduce the cost of calculating and recording the fair value of the embedded derivative feature separate from the debt security. Additionally, we elected the fair value option for a portion of other asset-backed securities for operational ease and to record and present the securities at fair value in future periods. Upon electing fair value option on July 1, 2010, these securities were reclassified into the trading category included in other invested assets and had a fair value of $407 million. Prior to electing fair value option, these securities were classified as available-for-sale fixed maturity securities.

 

Accounting for Transfers of Financial Assets

On January 1, 2010, we adopted new accounting guidance related to accounting for transfers of financial assets. This accounting guidance amends the previous guidance on transfers of financial assets by eliminating the qualifying special-purpose entity concept, providing certain conditions that must be met to qualify for sale accounting, changing the amount of gain or loss recognized on certain transfers and requiring additional disclosures. The adoption of this accounting guidance did not have a material impact on our consolidated financial statements. The elimination of the qualifying special-purpose entity concept requires that these entities be considered for consolidation as a result of the new guidance related to VIEs as discussed below.

Improvements to Financial Reporting by Enterprises Involved with VIEs

On January 1, 2010, we adopted new accounting guidance for determining which enterprise, if any, has a controlling financial interest in a VIE and requires additional disclosures about involvement in VIEs. Under this new accounting guidance, the primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. Upon adoption of this new accounting guidance, we were required to consolidate certain VIEs, including previously qualifying special-purpose entities and investment structures. We recorded a transition adjustment for the impact upon adoption to reflect the difference between the assets and liabilities of the newly consolidated entities and the amounts recorded for our interests in these entities prior to adoption. On January 1, 2010, we recorded a net cumulative effect adjustment of $104 million to retained earnings with a partial offset to accumulated other comprehensive income (loss) of $91 million related to the adoption of this new accounting guidance.

The assets and liabilities of the newly consolidated entities were as follows as of January 1, 2010:

 

(Amounts in millions)

   Carrying
value
(1)
     Adjustment for
election of fair
value option
(2)
    Amounts
recorded upon
consolidation
 

Assets

       

Restricted commercial mortgage loans

   $ 564       $ —        $ 564   

Restricted other invested assets

     409         (30     379   

Accrued investment income

     2         —          2   
  

 

 

    

 

 

   

 

 

 

Total assets

     975         (30     945   
  

 

 

    

 

 

   

 

 

 

Liabilities

       

Other liabilities

     138         —          138   

Borrowings related to securitization entities

     644         (80     564   
  

 

 

    

 

 

   

 

 

 

Total liabilities

     782         (80     702   
  

 

 

    

 

 

   

 

 

 

Net assets and liabilities of newly consolidated entities

   $ 193       $ 50        243   
  

 

 

    

 

 

   

 

 

 

Less: amortized cost of fixed maturity securities previously recorded (3)

          404   
       

 

 

 

Cumulative effect adjustment to retained earnings upon adoption, pre-tax

          (161

Tax effect

          57   
       

 

 

 

Net cumulative effect adjustment to retained earnings upon adoption

        $ (104
       

 

 

 

 

(1) 

Carrying value represents the amounts that would have been recorded in the consolidated financial statements on January 1, 2010 had we recorded the assets and liabilities in our financial statements from the date we first met the conditions for consolidation based on the criteria in the new accounting guidance.

(2) 

Amount represents the difference between book value and fair value of the investments and borrowings related to consolidated securitization entities where we have elected fair value option.

(3) 

Fixed maturity securities that were previously recorded had net unrealized investment losses of $91 million included in accumulated other comprehensive income (loss) as of December 31, 2009.

For commercial mortgage loans, the carrying amounts represent the unpaid principal balance less any allowance for losses. Restricted other invested assets are comprised of trading securities that are recorded at fair value. Trading securities represent asset-backed securities where we elected fair value option. Borrowings related to securitization entities are recorded at unpaid principal except for the borrowings related to entities where we elected fair value option for all assets and liabilities.

For certain entities consolidated upon adoption of the new accounting guidance on January 1, 2010, we elected fair value option to measure all assets and liabilities at current fair value with future changes in fair value being recording in income (loss). We elected fair value option for certain entities as a method to better present the offsetting changes in assets and liabilities related to third-party interests in those entities and eliminated the potential accounting mismatch between the measurement of the assets and derivatives of the entity compared to the borrowings issued by the entity. The entities where we did not elect fair value option did not have the same accounting mismatch since the assets held by the securitization entity and the borrowings of the entity were recorded at cost. See note 18 for additional information related to consolidation of VIEs.

The new accounting guidance related to consolidation of VIEs has been deferred for a reporting entity’s interest in an entity that has all of the attributes of an investment company as long as there is no implicit or explicit obligation to fund losses of the entity. For entities that meet these criteria, the new accounting guidance related to VIE consolidation would not be applicable until further guidance is issued. Accordingly, we did not have any impact upon adoption related to entities that meet the deferral criteria, such as certain limited partnership and fund investments.

Fair Value Measurements and Disclosures—Improving Disclosures about Fair Value Measurements

On January 1, 2010, we adopted new accounting guidance requiring additional disclosures for significant transfers between Level 1 and 2 fair value measurements and clarifications to existing fair value disclosures related to the level of disaggregation, inputs and valuation techniques. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Fair Value Measurements and Disclosures—Measuring Liabilities At Fair Value

On October 1, 2009, we adopted new accounting guidance related to measuring liabilities at fair valueThis accounting guidance clarified techniques for measuring the fair value of liabilities when quoted market prices for the identical liability are not available. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Fair Value Measurements and Disclosures—Investments In Certain Entities That Calculate Net Asset Value Per Share

On October 1, 2009, we adopted new accounting guidance related to fair value measurements and disclosures that provided guidance on the fair value measurement in certain entities that calculate net asset value per share. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles

On July 1, 2009, we adopted new accounting guidance related to the codification of accounting standards and the hierarchy of U.S. GAAP established by the FASB. This accounting guidance established two levels of U.S. GAAP, authoritative and nonauthoritative. The FASB Accounting Standards Codification (the “Codification”) is the source of authoritative, nongovernmental U.S. GAAP, except for rules and interpretive releases of the United States Securities and Exchange Commission (“SEC”), which are also sources of authoritative U.S. GAAP for SEC registrants. All other accounting literature is nonauthoritative. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Recognition and Presentation of Other-Than-Temporary Impairments

On April 1, 2009, we adopted new accounting guidance related to the recognition and presentation of other-than-temporary impairments. This accounting guidance amended the other-than-temporary impairment guidance for debt securities and modified the presentation and disclosure requirements for other-than-temporary impairment disclosures for debt and equity securities. This accounting guidance also amended the requirement for management to positively assert the ability and intent to hold a debt security to recovery to determine whether an other-than-temporary impairment exists and replaced this provision with the assertion that we do not intend to sell or it is not more likely than not that we will be required to sell a security prior to recovery. Additionally, this accounting guidance modified the presentation of other-than-temporary impairments for certain debt securities to only present the impairment loss in net income (loss) that represents the credit loss associated with the other-than-temporary impairment with the remaining impairment loss being presented in OCI. The following summarizes the components for the cumulative effect adjustment recorded on April 1, 2009 related to the adoption of this new accounting guidance:

 

(Amounts in millions)

   Accumulated other
comprehensive
income (loss)
    Retained
earnings
    Total
stockholders’
equity
 

Investment securities

   $ (588   $ 588      $ —     

Adjustment to DAC

     33        (26     7   

Adjustment to PVFP

     9        (7     2   

Adjustment to sales inducements

     5        (5     —     

Adjustment to certain benefit reserves

     —          1        1   

Provision for income taxes

     192        (196     (4
  

 

 

   

 

 

   

 

 

 

Net cumulative effect adjustment

   $ (349   $ 355      $ 6   
  

 

 

   

 

 

   

 

 

 

Interim Disclosures About Fair Value of Financial Instruments

On April 1, 2009, we adopted new accounting guidance related to interim disclosures about fair value of financial instruments. This accounting guidance amended the fair value disclosure requirements for certain financial instruments to require disclosures during interim reporting periods of publicly traded entities in addition to requiring them in annual financial statements. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Determining Fair Value When the Volume and Level of Activity For the Asset Or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly

On April 1, 2009, we adopted new accounting guidance related to determining fair value when the volume and level of activity for the asset or liability have significantly decreased and identifying transactions that are not orderly. This accounting guidance provided additional guidance for determining fair value when the volume or level of activity for an asset or liability has significantly decreased and identified circumstances that indicate a transaction is not orderly. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Fair Value Measurements of Certain Nonfinancial Assets and Liabilities

On January 1, 2009, we adopted new accounting guidance related to fair value measurements of certain nonfinancial assets and liabilities, such as impairment testing of goodwill and indefinite-lived intangible assets. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Disclosures About Derivative Instruments and Hedging Activities

On January 1, 2009, we adopted new accounting guidance related to disclosures about derivative instruments and hedging activities. This statement required enhanced disclosures about an entity’s derivative and hedging activities. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

Business Combinations

On January 1, 2009, we adopted new accounting guidance related to business combinations. This accounting guidance established principles and requirements for how an acquirer recognizes and measures certain items in a business combination, as well as disclosures about the nature and financial effects of a business combination. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

 

Noncontrolling Interests In Consolidated Financial Statements

On January 1, 2009, we adopted new accounting guidance related to noncontrolling interests in consolidated financial statements. This accounting guidance established accounting and reporting standards for noncontrolling interests in a subsidiary and for deconsolidation of a subsidiary. The adoption of this new accounting guidance did not have a material impact on our consolidated financial statements.

y) Retrospective Accounting Changes

On January 1, 2012, we adopted new accounting guidance requiring presentation of the components of net income (loss), the components of OCI and total comprehensive income either in a single continuous statement of comprehensive income (loss) or in two separate but consecutive statements. We chose to present two separate but consecutive statements. We adopted this new guidance retrospectively. The adoption of this new accounting guidance did not have a material impact on our consolidated financial results.

On January 1, 2012, we adopted new accounting guidance related to accounting for costs associated with acquiring or renewing insurance contracts. We adopted this new guidance retrospectively, which reduced retained earnings and stockholders’ equity by $1.2 billion as of January 1, 2009, and reduced net income (loss) by $63 million, $86 million and $12 million for the years ended December 31, 2011, 2010 and 2009, respectively. This new guidance results in lower amortization and fewer deferred costs, specifically related to underwriting, inspection and processing for contracts that are not issued, as well as advertising and customer solicitation.

Effective January 1, 2012, we changed our treatment of the liability for future policy benefits for our level premium term life insurance products when the liability for a policy falls below zero. Previously, the total liability for future policy benefits included negative reserves calculated at an individual policy level. Through 2010, we issued level premium term life insurance products whose premiums are contractually determined to be level through a period of time and then increase thereafter. Our previous accounting policy followed the accounting for traditional, long-duration insurance contracts where the reserves are calculated as the present value of expected benefit payments minus the present value of net premiums based on assumptions determined on the policy issuance date including mortality, interest, and lapse rates. This accounting has the effect of causing profits to emerge as a level percentage of premiums, subject to differences in assumed versus actual experience which flow through income as they occur, and for products with an increasing premium stream, such as the level premium term life insurance product, may result in negative reserves for a given policy.

More recent insurance-specific accounting guidance reflects a different accounting philosophy, emphasizing the balance sheet over the income statement, or matching, focus which was the philosophy in place when the traditional, long-duration insurance contract guidance was issued (the accounting model for traditional, long-duration insurance contracts draws upon the principles of matching and conservatism originating in the 1970’s, and does not specifically address negative reserves). More recent accounting models for long-duration contracts specifically prohibit negative reserves, e.g., non-traditional contracts with annuitization benefits and certain participating contracts. These recent accounting models did not impact the reserving for our level premium term life insurance products.

We believe that industry accounting practices for level premium term life insurance product reserving is mixed with some companies “flooring” reserves at zero and others applying our current accounting policy described above. In 2010, we stopped issuing new level premium term life insurance policies. Thus, as the level premium term policies reach the end of their level premium term periods, the portion of policies with negative reserves in relation to the reserve for all level premium term life insurance products will continue to increase. Our new method of accounting floors the liability for future policy benefits on each level premium term life insurance policy at zero. We believe that flooring reserves at zero is preferable in our circumstances as this alternative accounting policy will not allow negative reserves to accumulate on the balance sheet for this closed block of insurance policies. In implementing this change in accounting, no changes were made to the assumptions that were locked-in at policy inception. We implemented this accounting change retrospectively, which reduced retained earnings and stockholders’ equity by approximately $74 million as of January 1, 2009, and reduced net income (loss) by approximately $10 million, $4 million and $32 million for the years ended December 31, 2011, 2010 and 2009, respectively.

 

The following table presents the balance sheet as of December 31, 2011 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Assets

        

Total investments

   $ 71,904      $ —        $ —        $ 71,904   

Cash and cash equivalents

     4,488        —          —          4,488   

Accrued investment income

     691        —          —          691   

Deferred acquisition costs

     7,327        (2,134     —          5,193   

Intangible assets

     577        3        —          580   

Goodwill

     1,253        —          —          1,253   

Reinsurance recoverable

     16,982        —          16        16,998   

Other assets

     958        —          —          958   

Separate account assets

     10,122        —          —          10,122   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

   $ 114,302      $ (2,131   $ 16      $ 112,187   
  

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities and stockholders’ equity

        

Liabilities:

        

Future policy benefits

   $ 31,971      $ 3      $ 201      $ 32,175   

Policyholder account balances

     26,345        —          —          26,345   

Liability for policy and contract claims

     7,620        —          —          7,620   

Unearned premiums

     4,257        (34     —          4,223   

Other liabilities

     6,308        —          —          6,308   

Borrowings related to securitization entities

     396        —          —          396   

Non-recourse funding obligations

     3,256        —          —          3,256   

Long-term borrowings

     4,726        —          —          4,726   

Deferred tax liability

     1,636        (733     (65     838   

Separate account liabilities

     10,122        —          —          10,122   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

     96,637        (764     136        96,009   
  

 

 

   

 

 

   

 

 

   

 

 

 

Stockholders’ equity:

        

Class A common stock

     1        —          —          1   

Additional paid-in capital

     12,124        12        —          12,136   

Accumulated other comprehensive income (loss):

        

Net unrealized investment gains (losses):

        

Net unrealized gains (losses) on securities not other-than-temporarily impaired

     1,586        31        —          1,617   

Net unrealized gains (losses) on other-than-temporarily impaired securities

     (132     —          —          (132
  

 

 

   

 

 

   

 

 

   

 

 

 

Net unrealized investment gains (losses)

     1,454        31        —          1,485   
  

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives qualifying as hedges

     2,009        —          —          2,009   

Foreign currency translation and other adjustments

     558        (5     —          553   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total accumulated other comprehensive income (loss)

     4,021        26        —          4,047   

Retained earnings

     3,095        (1,391     (120     1,584   

Treasury stock, at cost

     (2,700     —          —          (2,700
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Genworth Financial, Inc.’s stockholders’ equity

     16,541        (1,353     (120     15,068   

Noncontrolling interests

     1,124        (14     —          1,110   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total stockholders’ equity

     17,665        (1,367     (120     16,178   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 114,302      $ (2,131   $ 16      $ 112,187   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

The following table presents the balance sheet as of December 31, 2010 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Assets

        

Total investments

   $ 68,437      $ —        $ —        $ 68,437   

Cash and cash equivalents

     3,132        —          —          3,132   

Accrued investment income

     733        —          —          733   

Deferred acquisition costs

     7,256        (2,061     —          5,195   

Intangible assets

     741        3        —          744   

Goodwill

     1,329        —          —          1,329   

Reinsurance recoverable

     17,191        —          15        17,206   

Other assets

     810        —          —          810   

Deferred tax asset

     1,100        11       —          1,111   

Separate account assets

     11,666        —          —          11,666   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

   $ 112,395      $ (2,047   $ 15      $ 110,363   
  

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities and stockholders’ equity

        

Liabilities:

        

Future policy benefits

   $ 30,717      $ 3      $ 185      $ 30,905   

Policyholder account balances

     26,978        —          —          26,978   

Liability for policy and contract claims

     6,933        —          —          6,933   

Unearned premiums

     4,541        (34     —          4,507   

Other liabilities

     6,085        —          —          6,085   

Borrowings related to securitization entities

     494        —          —          494   

Non-recourse funding obligations

     3,437        —          —          3,437   

Long-term borrowings

     4,952        —          —          4,952   

Deferred tax liability

     1,621        (700     (60     861   

Separate account liabilities

     11,666        —          —          11,666   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

     97,424        (731     125        96,818   
  

 

 

   

 

 

   

 

 

   

 

 

 

Stockholders’ equity:

        

Class A common stock

     1        —          —          1   

Additional paid-in capital

     12,095        12        —          12,107   

Accumulated other comprehensive income (loss):

        

Net unrealized investment gains (losses):

        

Net unrealized gains (losses) on securities not other-than-temporarily impaired

     21        20        —          41   

Net unrealized gains (losses) on other-than-temporarily impaired securities

     (121     —          —          (121
  

 

 

   

 

 

   

 

 

   

 

 

 

Net unrealized investment gains (losses)

     (100     20        —          (80
  

 

 

   

 

 

   

 

 

   

 

 

 

Derivatives qualifying as hedges

     924        —          —          924   

Foreign currency translation and other adjustments

     668        (6     —          662   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total accumulated other comprehensive income (loss)

     1,492        14        —          1,506   

Retained earnings

     2,973        (1,328     (110     1,535   

Treasury stock, at cost

     (2,700     —          —          (2,700
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Genworth Financial, Inc.’s stockholders’ equity

     13,861        (1,302     (110     12,449   

Noncontrolling interests

     1,110        (14     —          1,096   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total stockholders’ equity

     14,971        (1,316     (110     13,545   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 112,395      $ (2,047   $ 15      $ 110,363   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

The following table presents the income statement for year ended December 31, 2011 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Revenues:

        

Premiums

   $ 5,705      $ —        $ —        $ 5,705   

Net investment income

     3,380        —          —          3,380   

Net investment gains (losses)

     (220     —          —          (220

Insurance and investment product fees and other

     1,479        24       —          1,503   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     10,344        24       —          10,368   
  

 

 

   

 

 

   

 

 

   

 

 

 

Benefits and expenses:

        

Benefits and other changes in policy reserves

     5,926        —          15        5,941   

Interest credited

     794        —          —          794   

Acquisition and operating expenses, net of deferrals

     2,032        262        —          2,294   

Amortization of deferred acquisition costs and intangibles

     743        (145     —          598   

Goodwill impairment

     29        —          —          29   

Interest expense

     506        —          —          506   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total benefits and expenses

     10,030        117        15        10,162   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     314        (93     (15     206   

Provision for income taxes

     53        (30     (5     18   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     261        (63     (10     188   

Less: net income attributable to noncontrolling interests

     139        —          —          139   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income available to Genworth Financial, Inc.’s common stockholders

   $ 122      $ (63   $ (10   $ 49   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income available to Genworth Financial, Inc.’s common stockholders per common share:

        

Basic (1)

   $ 0.25      $ (0.13   $ (0.02   $ 0.10   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (1)

   $ 0.25      $ (0.13   $ (0.02   $ 0.10   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

May not total due to whole number calculation.

 

The following table presents the income statement for year ended December 31, 2010 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Revenues:

        

Premiums

   $ 5,854      $ —        $ —        $ 5,854   

Net investment income

     3,266        —          —          3,266   

Net investment gains (losses)

     (143     —          —          (143

Insurance and investment product fees and other

     1,112        —          —          1,112   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     10,089        —          —          10,089   
  

 

 

   

 

 

   

 

 

   

 

 

 

Benefits and expenses:

        

Benefits and other changes in policy reserves

     5,994        1       6        6,001   

Interest credited

     841        —          —          841   

Acquisition and operating expenses, net of deferrals

     1,965        252        —          2,217   

Amortization of deferred acquisition costs and intangibles

     756        (130     —          626   

Interest expense

     457        —          —          457   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total benefits and expenses

     10,013        123        6        10,142   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     76        (123     (6     (53

Benefit for income taxes

     (209     (37     (2     (248
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     285        (86     (4     195   

Less: net income attributable to noncontrolling interests

     143        —          —          143   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income available to Genworth Financial, Inc.’s common stockholders

   $ 142      $ (86   $ (4   $ 52   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income available to Genworth Financial, Inc.’s common stockholders per common share:

        

Basic (1)

   $ 0.29      $ (0.18   $ (0.01   $ 0.11   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (1)

   $ 0.29      $ (0.17   $ (0.01   $ 0.11   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

May not total due to whole number calculation.

 

The following table presents the income statement for year ended December 31, 2009 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Revenues:

        

Premiums

   $ 6,019      $ —        $ —        $ 6,019   

Net investment income

     3,033        —          —          3,033   

Net investment gains (losses)

     (1,041     —          —          (1,041

Insurance and investment product fees and other

     1,058        —          —          1,058   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total revenues

     9,069        —          —          9,069   
  

 

 

   

 

 

   

 

 

   

 

 

 

Benefits and expenses:

        

Benefits and other changes in policy reserves

     5,818        (2 )     50        5,866   

Interest credited

     984        —          —          984   

Acquisition and operating expenses, net of deferrals

     1,884        231        —          2,115   

Amortization of deferred acquisition costs and intangibles

     782        (213     —          569   

Interest expense

     393        —          —          393   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total benefits and expenses

     9,861        16        50        9,927   
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (792     (16     (50     (858

Benefit for income taxes

     (393     (4     (18     (415
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

     (399     (12     (32     (443

Less: net income attributable to noncontrolling interests

     61        —          —          61   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss available to Genworth Financial, Inc.’s common stockholders

   $ (460   $ (12   $ (32   $ (504
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss available to Genworth Financial, Inc.’s common stockholders per common share:

        

Basic (1)

   $ (1.02   $ (0.03   $ (0.07   $ (1.12
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (1)

   $ (1.02   $ (0.03   $ (0.07   $ (1.12
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(1) 

May not total due to whole number calculation.

 

The following table presents the cash flows from operating activities for the year ended December 31, 2011 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Cash flows from operating activities:

        

Net income

   $ 261      $ (63   $ (10   $ 188   

Adjustments to reconcile net income to net cash from operating activities:

        

Amortization of fixed maturity discounts and premiums and limited partnerships

     (77     —          —          (77

Net investment losses

     220        —          —          220   

Charges assessed to policyholders

     (690     —          —          (690

Acquisition costs deferred

     (899     262        —          (637

Amortization of deferred acquisition costs and intangibles

     743        (145     —          598   

Goodwill impairment

     29        —          —          29   

Deferred income taxes

     (309     (38     (5     (352

Gain on sale of subsidiary

     (20     (16 )     —          (36

Net increase in trading securities, held-for-sale investments and derivative instruments

     1,451        —          —          1,451   

Stock-based compensation expense

     31        —          —          31   

Change in certain assets and liabilities:

        

Accrued investment income and other assets

     (140     —          —          (140

Insurance reserves

     2,492        —          15        2,507   

Current tax liabilities

     131        —          —          131   

Other liabilities and policy-related balances

     (98     —          —          (98
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash from operating activities

   $ 3,125      $ —        $ —        $ 3,125   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

The following table presents the cash flows from operating activities for the year ended December 31, 2010 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Cash flows from operating activities:

        

Net income

   $ 285      $ (86   $ (4   $ 195   

Adjustments to reconcile net income to net cash from operating activities:

        

Amortization of fixed maturity discounts and premiums and limited partnerships

     (55     —          —          (55

Net investment losses

     143        —          —          143   

Charges assessed to policyholders

     (506     —          —          (506

Acquisition costs deferred

     (839     252        —          (587

Amortization of deferred acquisition costs and intangibles

     756        (130     —          626   

Deferred income taxes

     (294     (37     (2     (333

Net decrease in trading securities, held-for-sale investments and derivative instruments

     (100     —          —          (100

Stock-based compensation expense

     44        —          —          44   

Change in certain assets and liabilities:

        

Accrued investment income and other assets

     (33     —          —          (33

Insurance reserves

     2,406        1       6        2,413   

Current tax liabilities

     (173     —          —          (173

Other liabilities and policy-related balances

     (298     —          —          (298
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash from operating activities

   $ 1,336      $ —        $ —        $ 1,336   
  

 

 

   

 

 

   

 

 

   

 

 

 

 

The following table presents the cash flows from operating activities for the year ended December 31, 2009 reflecting the impact of the accounting changes that were retrospectively adopted on January 1, 2012:

 

(Amounts in millions)

   As Originally
Reported
    Effect of
DAC Change
    Effect of
Reserve Change
    As Currently
Reported
 

Cash flows from operating activities:

        

Net loss

   $ (399   $ (12   $ (32   $ (443

Adjustments to reconcile net loss to net cash from operating activities:

        

Amortization of fixed maturity discounts and premiums and limited partnerships

     84        —          —          84   

Net investment losses

     1,041        —          —          1,041   

Charges assessed to policyholders

     (442     —          —          (442

Acquisition costs deferred

     (707     231        —          (476

Amortization of deferred acquisition costs and intangibles

     782        (213     —          569   

Deferred income taxes

     (476     (4     (18     (498

Gain on sale of subsidiary

     (4     —          —          (4

Net decrease in trading securities, held-for-sale investments and derivative instruments

     (59     —          —          (59

Stock-based compensation expense

     26        —          —          26   

Change in certain assets and liabilities:

        

Accrued investment income and other assets

     (90     —          —          (90

Insurance reserves

     2,763        (2 )     50        2,811   

Current tax liabilities

     (119     —          —          (119

Other liabilities and policy-related balances

     (469     —          —          (469
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash from operating activities

   $ 1,931      $ —        $ —        $ 1,931   
  

 

 

   

 

 

   

 

 

   

 

 

 

z) Accounting Pronouncements Not Yet Adopted

In May 2011, the FASB issued new accounting guidance for fair value measurements. This new accounting guidance clarifies existing fair value measurement requirements and changes certain fair value measurement principles and disclosure requirements that will be effective for us on January 1, 2012. We do not expect the adoption of this accounting guidance to have a material impact on our consolidated financial statements.

In April 2011, the FASB issued new accounting guidance for repurchase agreements and other agreements that both entitle and obligate a transferor to repurchase or redeem financial assets before their maturity. The new guidance removes the requirement to consider a transferor’s ability to fulfill its contractual rights from the criteria when determining effective control and is effective, for us, prospectively to any transactions occurring on or after January 1, 2012. We do not expect the adoption of this accounting guidance to have a material impact on our consolidated financial statements.

Earnings (Loss) Per Share
Earnings (Loss) Per Share

(3) Earnings (Loss) Per Share

Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted shares outstanding for the periods indicated:

 

(Amounts in millions, except per share amounts)

   2011      2010      2009  

Net income (loss)

   $ 188       $ 195       $ (443

Less: net income attributable to noncontrolling interests

     139         143         61   
  

 

 

    

 

 

    

 

 

 

Net income (loss) available to Genworth Financial, Inc.’s common stockholders

   $ 49       $ 52       $ (504
  

 

 

    

 

 

    

 

 

 

Basic per common share:

        

Net income (loss)

   $ 0.38       $ 0.40       $ (0.98

Less: net income attributable to noncontrolling interests

     0.28         0.29         0.14   
  

 

 

    

 

 

    

 

 

 

Net income (loss) available to Genworth Financial, Inc.’s common stockholders (1)

   $ 0.10       $ 0.11       $ (1.12
  

 

 

    

 

 

    

 

 

 

Diluted per common share:

        

Net income (loss)

   $ 0.38       $ 0.40       $ (0.98

Less: net income attributable to noncontrolling interests

     0.28         0.29         0.14   
  

 

 

    

 

 

    

 

 

 

Net income (loss) available to Genworth Financial, Inc.’s common stockholders (1)

   $ 0.10       $ 0.11       $ (1.12
  

 

 

    

 

 

    

 

 

 

Weighted-average shares used in basic earnings per common share calculations

     490.6         489.3         451.1   

Potentially dilutive securities:

        

Stock options, restricted stock units and stock appreciation rights

     2.9         4.6         —     
  

 

 

    

 

 

    

 

 

 

Weighted-average shares used in diluted earnings per common share calculations (2)

     493.5         493.9         451.1   
  

 

 

    

 

 

    

 

 

 

 

(1) 

May not total due to whole number calculation.

(2) 

Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for the year ended December 31, 2009, we were required to use basic weighted-average common shares outstanding in the calculation of the 2009 diluted loss per share, as the inclusion of shares for stock options, restricted stock units (“RSUs”) and stock appreciation rights (“SARs”) of 1.9 million would have been antidilutive to the calculation. If we had not incurred a net loss in 2009, dilutive potential common shares would have been 453.0 million.

On September 21, 2009, we completed the public offering of 55.2 million shares of our Class A Common Stock, par value $0.001 per share (including the exercise in full of the underwriters’ option to purchase up to an additional 7.2 million shares of our Class A Common Stock). Net proceeds were $622 million.

Investments
Investments

(4) Investments

(a) Net Investment Income

Sources of net investment income were as follows for the years ended December 31:

 

(Amounts in millions)

   2011     2010     2009  

Fixed maturity securities—taxable

   $ 2,697      $ 2,619      $ 2,458   

Fixed maturity securities—non-taxable

     35        59        107   

Commercial mortgage loans

     365        391        432   

Restricted commercial mortgage loans related to securitization entities (1)

     40        39        —     

Equity securities

     19        14        16   

Other invested assets (2)

     162        104        (82

Restricted other invested assets related to securitization entities (1)

     —          2        —     

Policy loans

     120        112        143   

Cash, cash equivalents and short-term investments

     37        21        49   
  

 

 

   

 

 

   

 

 

 

Gross investment income before expenses and fees

     3,475        3,361        3,123   

Expenses and fees

     (95     (95     (90
  

 

 

   

 

 

   

 

 

 

Net investment income

   $ 3,380      $ 3,266      $ 3,033   
  

 

 

   

 

 

   

 

 

 

 

(1) 

See note 18 for additional information related to consolidated securitization entities.

(2) 

Included in other invested assets was $15 million, $14 million and $7 million of net investment income related to trading securities in 2011, 2010 and 2009, respectively.

(b) Net Investment Gains (Losses)

The following table sets forth net investment gains (losses) for the years ended December 31:

 

(Amounts in millions)

   2011     2010     2009  

Available-for-sale securities:

      

Realized gains

   $ 210      $ 156      $ 255   

Realized losses

     (160     (151     (226
  

 

 

   

 

 

   

 

 

 

Net realized gains (losses) on available-for-sale securities

     50        5        29   
  

 

 

   

 

 

   

 

 

 

Impairments:

      

Total other-than-temporary impairments

     (118     (122     (1,499

Portion of other-than-temporary impairments included in other comprehensive income (loss)

     (14     (86     441   
  

 

 

   

 

 

   

 

 

 

Net other-than-temporary impairments

     (132     (208     (1,058
  

 

 

   

 

 

   

 

 

 

Trading securities

     27        19        22   

Commercial mortgage loans

     6        (29     (28

Net gains (losses) related to securitization entities (1)

     (47     (3     —     

Derivative instruments (2)

     (99     50        21   

Contingent purchase price valuation change

     (25     —          —     

Other

     —          23        (27
  

 

 

   

 

 

   

 

 

 

Net investment gains (losses)

   $ (220   $ (143   $ (1,041
  

 

 

   

 

 

   

 

 

 

 

(1) 

See note 18 for additional information related to consolidated securitization entities.

(2) 

See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).

We generally intend to hold securities in unrealized loss positions until they recover. However, from time to time, our intent on an individual security may change, based upon market or other unforeseen developments. In such instances, we sell securities in the ordinary course of managing our portfolio to meet diversification, credit quality, yield and liquidity requirements. If a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we determined that we have the intent to sell the securities or it is more likely than not that we will be required to sell the securities prior to recovery. The aggregate fair value of securities sold at a loss during the years ended December 31, 2011, 2010 and 2009 was $1,884 million, $1,932 million and $1,513 million, respectively, which was approximately 93%, 93% and 88%, respectively, of book value.

The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the years ended December 31:

 

(Amounts in millions)

   2011     2010     2009  

Beginning balance

   $ 784      $ 1,059      $ —     

Adoption of new accounting guidance related to other-than-temporary impairments

     —          —          1,204   

Adoption of new accounting guidance related to securitization entities

     —          (36     —     

Additions:

      

Other-than-temporary impairments not previously recognized

     39        63        120   

Increases related to other-than-temporary impairments previously recognized

     82        117        227   

Reductions:

      

Securities sold, paid down or disposed

     (259     (419     (485

Securities where there is intent to sell

     —          —          (7
  

 

 

   

 

 

   

 

 

 

Ending balance

   $ 646      $ 784      $ 1,059   
  

 

 

   

 

 

   

 

 

 

 

c) Unrealized Investment Gains and Losses

Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31:

 

(Amounts in millions)

   2011     2010     2009  

Net unrealized gains (losses) on investment securities:

      

Fixed maturity securities

   $ 3,742      $ 511      $ (2,245

Equity securities

     5        9        20   

Other invested assets

     (30     (22     (29
  

 

 

   

 

 

   

 

 

 

Subtotal

     3,717        498        (2,254

Adjustments to DAC, PVFP, sales inducements and benefit reserves

     (1,303     (553     127   

Income taxes, net

     (840     25        761   
  

 

 

   

 

 

   

 

 

 

Net unrealized investment gains (losses)

     1,574        (30     (1,366

Less: net unrealized investment gains (losses) attributable to noncontrolling interests

     89        50        39   
  

 

 

   

 

 

   

 

 

 

Net unrealized investment gains (losses) attributable to Genworth Financial, Inc.

   $ 1,485      $ (80